HealthLeaders Media October 6, 2023
The agency is once again extending a pandemic-era waiver enabling providers to prescribe controlled substances via telemedicine without first needing an in-person checkup, and is expected to propose new long-term guidelines soon.
KEY TAKEAWAYS
– The DEA has been under pressure to develop a special registration process to enable providers to use telemedicine to prescribe controlled substances since the practice was strictly regulated through the Ryan Haight Online Pharmacy Consumer Protection Act of 2008.
– The agency issued a waiver during the pandemic to enable providers to use telemedicine without first needing to conduct an in-person checkup with a patient, and has now extended that waiver through the end of 2024.
– The DEA had proposed long-term guidelines for telemedicine...
Today's Sponsors
Today's Sponsor